Capivasertib
Capivasertib is an oral serine/threonine protein kinase AKT inhibitor with potential anti-tumor activity. Capivasertib binds and inhibits all AKT isoforms. Inhibition of AKT prevents phosphorylation of AKT substrates, which mediates cellular processes such as cell division, apoptosis, and glucose and fatty acid metabolism.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0131 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, inquire |